Today's Earnings Movers 11/09: BSFT, APEI, GHDX, TTGT, PCLN Higher; MBLX, DF, CSKI, ENOC, BEAT Lower

By
A A A

HIGHER:

  • Broadsoft (Nasdaq: BSFT) 43% HIGHER; reports Q3 EPS of $0.08, 15 cents better than the analyst estimate of ($0.07). Revenue for the quarter was $22.3 million, which compares to the estimate of $19.60 million. For the fourth quarter of 2010, BroadSoft anticipates revenue of $31.0 to $32.0 million (Consensus is $30.17M) For the fourth quarter, the Company expects to achieve earnings per share on a non-GAAP basis of $0.28 to $0.31 per diluted share (Consensus is $0.29)

  • American Public Education (Nasdaq: APEI) 21% HIGHER; reports Q3 EPS of $0.30, 1 cent better than the analyst estimate of $0.29. Revenue for the quarter was $48.3 million, which compares to the estimate of $47.31 million. Sees Q4 EPS of 45-47c, vs. the consensus of 44c. Sees net course registrations up 26-29%.

  • Genomic Health (Nasdaq: GHDX) 16% HIGHER; reports Q3 EPS of $0.12, 12 cents better than the analyst estimate of $0.00. Revenue for the quarter was $46.3 million, which compares to the estimate of $44.90 million.

  • TechTarget (Nasdaq: TTGT) 15% HIGHER; reports Q3 EPS of $0.05, ex-items, inline with the analyst estimate of $0.05. Revenue for the quarter was $22 million, which compares to the estimate of $22.76 million. Sees Q4 sales of $25.5-$26.5 million, vs. the consensus of $25.6 million. Also announced 10 million share buyback at $6/share.

  • Priceline.com (Nasdaq: PCLN) 9% HIGHER; reports Q3 EPS of $5.33, versus the analyst estimate of $4.97. Revenue for the quarter was $1 billion, which compares to the estimate of $973.63 million. Sees Q410 EPS of $2.91 - $3.06, versus the consensus of $2.68. sees Q410 sales up about 31 - 36% from Q409.

    LOWER:

      Metabolix (Nasdaq: MBLX) 20% LOWER; reports Q3 loss of $0.37, 2 cents worse than the analyst estimate of ($0.35). Revenue for the quarter was $46,000, which compares to the estimate of $250,000.

    • Dean Foods ( DF ) 16% LOWER; reports Q3 EPS of $0.13, ex-items, 8 cents lower than the consensus of $0.21. Revenue for the quarter came in at $3.1 billion, compared to the consensus of $3.04 billion. Sees Q4 adj-EPS of 13-18c, vs. the consensus of 27c.

    • China Sky One Medical (Nasdaq: CSKI) 13% LOWER; reports Q3 adjusted EPS of $0.40, versus the consensus of $0.74. Revenue for the quarter came in at $36.2 million, compared to the consensus of $45.75 million. Reiterates FY10 outloo

    • EnerNOC (Nasdaq: ENOC) 12% LOWER; reports Q3 EPS of $1.81, vs. the analyst estimate of $1.56. Revenue for the quarter was $162.8 million, which compares to the estimate of $160.81 million. Sees Q4 sales of $20-$24 million with a loss of 62-73c. The Street is looking for Q4 sales of $29.41 million and a loss of 65c.

    • CardioNet (Nasdaq: BEAT) 12% LOWER; reports a Q3 loss of $0.25, 20 cents worse than the analyst estimate of ($0.05). Revenue for the quarter was $27.5 million, which compares to the estimate of $32.04 million.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Stocks

Referenced Stocks: APEI , BEAT , BSFT , CSKI , DF

StreetInsider.com

StreetInsider.com

More from StreetInsider.com:

Related Videos

Stocks

Referenced

Most Active by Volume

61,354,178
  • $10.59 ▲ 13.26%
57,732,182
  • $16.27 ▲ 1.12%
51,991,548
  • $103.30 ▲ 0.78%
48,129,834
  • $20.65 ▲ 5.52%
41,623,916
  • $12.63 ▲ 8.13%
34,295,241
  • $76.68 ▲ 2.49%
31,519,079
  • $34.57 ▼ 1.00%
28,847,879
  • $3.64 ▲ 0.28%
As of 9/2/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com